Innovation Fund Invests in New Project to Advance Clinical Research
It should be easier for Danes to sign up for and participate in clinical trials. An investment of DKK 15.6 million DKK from the Innovation Fund launches a national project to move clinical research closer to the citizens. It is a number of health Denmark's heaviest and most knowledgeable actors that are behind a strong public-private partnership.
Project to contribute in three ways:
- The implementation of a National Experimental Overview. A platform that can give citizens an overview of clinical trials in Denmark, as well as where they can turn to to find out more.
- The implementation of a Digital Recruitment Platform that is under development. A platform where access to health data creates better conditions for contact between trial participants and those responsible for clinical trials.
- Strengthened framework for patient-centered decentralized clinical trials.
Read more about this investment here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
